Literature DB >> 29802779

Validation of a short cognitive battery to screen for fitness-to-drive of people with multiple sclerosis.

A E Akinwuntan1, D Backus2, J Grayson3, H Devos1.   

Abstract

BACKGROUND AND
PURPOSE: Some symptoms of multiple sclerosis (MS) affect driving. In a recent study, performance on five cognitive tests predicted the on-road test performance of individuals with relapsing-remitting MS with 91% accuracy, 70% sensitivity and 97% specificity. However, the accuracy with which the battery will predict the driving performance of a different cohort that includes all types of MS is unknown.
METHODS: Participants (n = 118; 48 ± 9 years of age; 97 females) performed a comprehensive off-road evaluation that lasted about 3 h and a standardized on-road test that lasted approximately 45 min over a 2-day period within the same week. Performance on the five cognitive tests was used to predict participants' performance on the standardized on-road test.
RESULTS: Performance on the five tests together predicted outcome of the on-road test with 82% accuracy, 42% sensitivity and 90% specificity.
CONCLUSIONS: The accuracy of predicting the on-road performance of a new MS cohort using performance on the battery of five cognitive tests remained very high (82%). The battery, which was administrable in <45 min and cost ~$150, was better at identifying those who actually passed the on-road test (90% specificity). The sensitivity (42%) of the battery indicated that it should not be used as the sole determinant of poor driving-related cognitive skills. A fail performance on the battery should only imply that more comprehensive testing is warranted.
© 2018 EAN.

Entities:  

Keywords:  cognition; driving; evaluation; multiple sclerosis; vision

Mesh:

Year:  2018        PMID: 29802779     DOI: 10.1111/ene.13690

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  1 in total

Review 1.  Driving and Alzheimer's dementia or mild cognitive impairment: a systematic review of the existing guidelines emphasizing on the neurologist's role.

Authors:  Petros Stamatelos; Alexandra Economou; Leonidas Stefanis; George Yannis; Sokratis G Papageorgiou
Journal:  Neurol Sci       Date:  2021-09-28       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.